TRINA LA PHARMD CANDIDATE OCT 18TH, 2011
-
Upload
enrique-rios -
Category
Documents
-
view
22 -
download
0
description
Transcript of TRINA LA PHARMD CANDIDATE OCT 18TH, 2011
TRINA LAPHARMD CANDIDATE
OCT 18TH, 2011
Atrial Fibrillation & Risk of Dementia: A Prospective Cohort
Study
Sascha Dublin, MD, PhD, Melissa L. Anderson, MS, et al.
JAGS 2011; 59: 1369- 1375
Background study
By 2030, nearly one in five Americans will be aged 65 & older
Cognitive impairment is one of the most feared conditions associated with aging
In the United States, the estimated costs of Alzheimer’s disease (AD) are $172 billion each year
Evidence is emerging that atrial fibrillation may contribute to dementia risk
Background-Alzheimer’s disease
Definition: A progressive dementia affecting cognition, behavior,
& functional status with no known cause or cure Patients eventually lose cognitive, analytical, and
physical functioning, and the disease is ultimately fatal
Risk factors Age Family history Apolipoprotein E (ApoE) gene Diabetes Vascular disease (particular stroke)
Background-Atrial Fibrillation (AF)
AF is characterized as an extremely rapidly (400-600 atrial beats/min) & disorganized atrial activation
Risk factors Advanced ages Cardiovascular disease Metabolic or hemodynamic derangements COPD Pulmonary embolism Pneumonia
Objective
Primary outcomes were incident all-cause dementia & possible or probable through the Adult Changes in Thought Study (ACT)
Study Design & Setting
A population-based cohort study set within Group Health (GH), an integrated healthcare delivery system
ACT recruited community-dwelling adults without dementia aged 65 & older
The study was conducted from 1994 to 2008Participates were excluded from the study if
History of stroke at baseline History of transition ischemic attack
Measurement and Population
Measurement: AF was identified if there were at least 2 clinical
encounters with ICD-9 codes for AF or atrial flutter on different days within a 12 month period
Participants were screened every 2 years using the Cognitive Abilities Screening Instrument (range 0-100), with detailed neuropsychological & clinical assessment of those scoring <86
Review of results of recent cranial imaging if available Use Diagnostic & Statistical Manual of Mental
Disorder criteria to identify cases of dementia
Results
3743 participated but 2781 qualified to be in sensitivity analysis
At baseline: AF: 132 (4.3%) participants
Mean of 6.8 years of follow-up: AF: 370 (12.2%) more participants
572 participants (18.8%) developed dementia 499 participants with AD
The adjusted hazard ratio associated with AF 1.38 (95% CI: 1.10-1.73) for all-cause dementia 1.5 (95% CI: 1.16-1.94) for possible or probable AD
Results were similar for participants with & without clinically recognized stroke during follow-up & in sensitivity analyses examining only probable AD
Author’s conclusion
AF is associated with higher risk of developing AD & dementia
Future studies should examine whether specific treatments, including optimal anticoagulation, can decrease this risk
Discussion
In this population-based study of older adults AF was associated
with a 40% to 50% higher risk of AD & all-cause dementia, independent of stroke
This higher risk persisted after adjustment for many CV risk factors & diseases
Some biological mechanisms that are associated AF & Dementia
AF incomplete atrial
emptying, which may lead to thrombus formation, resulting in systemic embolization in the brain & causing stroke
Silent cerebral emboli Cerebral
hypoperfusion due to irregular heart beat
These mechanism may be associated with other neuropathological entities associated with dementia Neurofibrillary tangles Lewy bodies Hippocampal sclerosis
AF & dementia may share underlying risk factors Inflammation
Other Relative Studies
Three of eight longitudinal studies reported that participants with AF were at higher risk of dementia One study found this association only in participants
with mild cognitive impairment Another found an association at 5 years of follow up
Five longitudinal studies found no association
The studies that found an association examined a younger population than those that found no associations
Study limitations
The methods used to detect AF & dementia varied widely
Some studies used measures of dementia that have poor sensitivity or specific
Diagnoses of dementia & AD were based on clinical criteria without neuro-imaging studies
Cases of vascular or mixed dementia may have been misclassified as AD